Romosozumab Recruiting Phase 4 Trials for Spinal Cord Injuries / Osteoporosis Prevention

IndicationsStatusPurposePhase
RecruitingPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT05180032Treatment With Romosozumab to Improve Bone Mineral Density and Architecture in Chronic SCI